Fan X, Zhang G. Comment on "Real-world outcomes of ustekinumab, vedolizumab, and tumor necrosis factor inhibitors in very-early-onset inflammatory bowel disease": treatment comparison or treatment sequencing? J Gastroenterol 2026 May 27. doi: 10.1007/s00535-026-02451.
PMID: 42201397